Findings from UKMasto Survey on COVID-19 Vaccinations in Mastocytosis Published in the Journal HemaSphere

Using a survey, we sought to capture the experience of people with mast cell diseases when having their COVID-19 vaccination, beginning in February 2021.  We understood that these patients and their doctors could be concerned about how well the vaccinations would be tolerated.  We are pleased to share a peer-reviewed letter published today in HemaSphere, the journal of the European Hematology Association, that focuses on the experience of adults with mastocytosis in the immediate period after first vaccination with Astra Zeneca, Pfizer or Moderna vaccines.

Many thanks to our collaborators, Dr Priya Sriskandarajah, Dr Andrew Whyte and Dr Deepti Radia for their hard work to get this data published! Click on the link to download a copy of the paper.

Sriskandarajah, Priya; Hobart, Jess; Radia, Deepti H.; Whyte, Andrew F; A UK Survey Examining the Experience of Adults With Mastocytosis Receiving COVID-19 Vaccination, HemaSphere: November 2021 – Volume 5 – Issue 11 – p e650